Iannone Robert — SEC Form 4 filings
SEC reporting owner CIK 1737329. 16 Form 4 filings on record with FilingPulse; latest filed 2026-08-31.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-01-19 to 2026-08-31. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 10 legs across 4 filings — 93,563 shares, $21,725,573 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
- Largest priced transaction: sale of 19,639 shares @ $250.60 ($4,921,596) in Jazz Pharmaceuticals plc, filed 2026-08-31.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | EVP, Global Head of R&D & CMO | 13 | — | 10 legs · 93,563 sh · $21,725,573 | 22 |
| Autolus Therapeutics plc (AUTL) | Director | 1 | — | — | 2 |
| PLIANT THERAPEUTICS, INC. (PLRX) | Director | 1 | — | — | 1 |
| iTeos Therapeutics, Inc. (ITOS) | Director | 1 | — | — | 1 |
Form 4 filings — Iannone Robert
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-31 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Option exercise (M): 26,116 @ $113.10 · Option exercise (M): 884 @ $113.10 · Option exercise (M): 27,584 @ $137.12 · Option exercise (M): 2,916 @ $137.12 · Sale (S): 18,187 @ $247.86 · Sale (S): 11,423 @ $248.67 · +8 more | EDGAR |
| 2026-07-13 | 4 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 3,764 @ $237.72 | EDGAR |
| 2026-07-01 | 4 | Autolus Therapeutics plc (AUTL) | Grant/award (A): 31,667 (derivative) @ $0 · Grant/award (A): 47,500 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 6,209 @ $188.69 | EDGAR |
| 2026-03-02 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 14,822 @ $0 | EDGAR |
| 2026-01-21 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 11,699 @ $0 · Tax withholding (F): 4,140 @ $171.16 | EDGAR |
| 2025-11-19 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 7,159 @ $168.26 | EDGAR |
| 2025-03-12 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Sale (S): 2,403 @ $138.41 | EDGAR |
| 2025-03-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Disposition to issuer (D): 5,239 @ $138.95 · Sale (S): 5,532 @ $138.21 · Sale (S): 1,548 @ $140 | EDGAR |
| 2025-03-03 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 17,718 @ $0 · Grant/award (A): 8,859 @ $0 | EDGAR |
| 2025-01-22 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 7,506 @ $0 · Tax withholding (F): 2,181 @ $122.62 | EDGAR |
| 2024-06-13 | 4 | iTeos Therapeutics, Inc. (ITOS) | Grant/award (A): 24,200 (derivative) @ $0 | EDGAR |
| 2024-03-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 4,294 @ $117.53 | EDGAR |
| 2024-03-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 16,928 @ $0 | EDGAR |
| 2024-01-19 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 5,970 @ $0 · Tax withholding (F): 1,730 @ $119.13 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1737329 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →